Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Infection prevention product manufacturer Tristel posted a 25% rise in first-half profit that exceeded its expectations.
Pre-tax profit for the six months through December rose to £2.8m, up from £2.2m on-year.
Revenue climbed 22% to £14.6m, with overseas sales up 30% to £8.3m.
Tristel declared an interim dividend of 2.34p per share, up 15% on-year.
Chief Executive Paul Swinney said the company's sales growth had exceeded its target range of 10-15%, while margins had also improved.
Swinney said the current coronavirus outbreak would be a 'powerful influence' on global healthcare systems for greater investment in infection prevention and control.
'As a globally recognised infection prevention brand, with some of the world's best-known disinfection technology, there are significant macro factors that will support Tristel's continued progress,' he added.